Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Toxicol Lett. 2020 Nov 27;338:10–20. doi: 10.1016/j.toxlet.2020.11.015

Table 3.

Relative contributions of P450 isozymes to in vivo hepatic sudoxicam and meloxicam clearance and/or bioactivation

Substrate Metabolite Percent contributions of individual isozymes for each reactiona
CYP1A2 CYP2C8 CYP2C9 CYP2C19 CYP3A4
sudoxicam glyoxal - 84.4 - 4.3 11.2

meloxicam methylglyoxal 100 - - - -

5-hydroxymethyl-meloxicam - - 91.6 - 8.4
a

Calculations based on extrapolations of kinetic efficiencies and reported levels of P405 isozymes as described under Materials and Methods.